The University of Chicago Header Logo

Hedy Kindler

Concepts (792)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mesothelioma
117
2026
342
18.580
Why?
Pleural Neoplasms
72
2026
204
12.280
Why?
Pancreatic Neoplasms
58
2025
782
7.980
Why?
Lung Neoplasms
69
2026
2474
4.860
Why?
Antineoplastic Combined Chemotherapy Protocols
70
2024
2666
4.630
Why?
Deoxycytidine
38
2020
218
3.900
Why?
Adenocarcinoma
33
2022
1215
3.700
Why?
Peritoneal Neoplasms
17
2025
196
2.720
Why?
Neoplasm Staging
51
2026
2087
2.640
Why?
Phthalazines
7
2023
60
2.620
Why?
Antineoplastic Agents
40
2020
2386
2.280
Why?
Antimetabolites, Antineoplastic
21
2018
246
2.100
Why?
Aged
166
2026
21986
1.930
Why?
Aged, 80 and over
101
2025
7461
1.860
Why?
Piperazines
9
2023
308
1.750
Why?
Middle Aged
164
2026
29642
1.660
Why?
Humans
277
2026
98799
1.620
Why?
Germ-Line Mutation
14
2026
404
1.530
Why?
Pyrimidines
8
2025
416
1.460
Why?
Colonic Neoplasms
15
2022
592
1.440
Why?
Male
173
2026
47475
1.430
Why?
Female
175
2026
51997
1.420
Why?
Gastrointestinal Neoplasms
4
2020
114
1.420
Why?
Antibodies, Monoclonal
18
2024
1422
1.400
Why?
Neoplasm Recurrence, Local
21
2023
1538
1.380
Why?
Ubiquitin Thiolesterase
10
2026
73
1.300
Why?
Antibodies, Monoclonal, Humanized
23
2024
1105
1.280
Why?
Adult
113
2026
29698
1.230
Why?
Stomach Neoplasms
9
2020
321
1.220
Why?
Antineoplastic Agents, Immunological
7
2021
238
1.220
Why?
BRCA1 Protein
6
2023
222
1.220
Why?
Survival Rate
34
2026
2057
1.210
Why?
Glutamates
15
2014
85
1.210
Why?
Pemetrexed
21
2021
76
1.200
Why?
Fluorouracil
17
2020
543
1.190
Why?
Carcinoma, Pancreatic Ductal
7
2023
158
1.180
Why?
Maintenance Chemotherapy
2
2020
96
1.160
Why?
Guanine
15
2014
194
1.150
Why?
Neoplasms
25
2025
3382
1.150
Why?
Tumor Suppressor Proteins
9
2026
318
1.110
Why?
BRCA2 Protein
5
2023
178
1.100
Why?
Colorectal Neoplasms
16
2024
1120
1.070
Why?
Neurofibromin 2
3
2025
31
1.060
Why?
Pyridines
7
2016
317
1.060
Why?
Disease-Free Survival
26
2022
1196
1.050
Why?
Immunoconjugates
4
2024
140
1.020
Why?
Treatment Outcome
63
2025
9806
1.010
Why?
Protein Kinase Inhibitors
9
2016
642
0.980
Why?
Ovarian Neoplasms
3
2023
829
0.950
Why?
Esophageal Neoplasms
6
2020
355
0.940
Why?
Cisplatin
19
2021
578
0.930
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2025
110
0.910
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2025
11
0.900
Why?
Adaptor Proteins, Signal Transducing
3
2025
316
0.860
Why?
Bevacizumab
16
2023
255
0.830
Why?
Quinazolines
7
2012
222
0.830
Why?
Biomarkers, Tumor
17
2026
1786
0.830
Why?
Immunotherapy
6
2025
831
0.810
Why?
Prognosis
32
2026
4139
0.810
Why?
Leucovorin
11
2020
205
0.810
Why?
Glucuronosyltransferase
3
2020
178
0.800
Why?
Kaplan-Meier Estimate
19
2020
909
0.750
Why?
Survival Analysis
24
2020
1530
0.750
Why?
Camptothecin
9
2017
198
0.720
Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2019
90
0.710
Why?
Pneumonectomy
8
2023
222
0.670
Why?
Genes, BRCA2
2
2019
162
0.670
Why?
Diet
7
2022
472
0.660
Why?
Genes, BRCA1
2
2019
191
0.660
Why?
Combined Modality Therapy
16
2026
1754
0.640
Why?
Liver Neoplasms
11
2011
840
0.620
Why?
Molecular Targeted Therapy
2
2020
331
0.610
Why?
Neoplasm Metastasis
16
2024
1102
0.600
Why?
Quality of Life
11
2023
1904
0.600
Why?
Angiogenesis Inhibitors
6
2021
281
0.580
Why?
Clinical Trials as Topic
16
2019
1128
0.580
Why?
Vascular Endothelial Growth Factor A
8
2021
402
0.550
Why?
GPI-Linked Proteins
6
2024
58
0.550
Why?
Double-Blind Method
13
2019
1793
0.540
Why?
Chemotherapy, Adjuvant
11
2022
527
0.540
Why?
Practice Guidelines as Topic
6
2025
1116
0.530
Why?
Tomography, X-Ray Computed
15
2024
2680
0.530
Why?
Drug Administration Schedule
14
2019
837
0.530
Why?
Disease Progression
12
2023
1621
0.520
Why?
Transcription Factors
1
2025
1724
0.510
Why?
Biliary Tract Neoplasms
3
2019
39
0.500
Why?
Organoplatinum Compounds
6
2017
95
0.500
Why?
Asbestos
3
2026
25
0.490
Why?
Rare Diseases
1
2016
75
0.470
Why?
Hedgehog Proteins
2
2016
104
0.460
Why?
Anilides
1
2015
50
0.450
Why?
Cytoreduction Surgical Procedures
4
2024
105
0.450
Why?
Gallbladder Neoplasms
2
2005
24
0.440
Why?
Maytansine
4
2024
17
0.440
Why?
Radiation Injuries
6
1999
160
0.430
Why?
Follow-Up Studies
22
2022
4049
0.420
Why?
Germ Cells
3
2022
137
0.410
Why?
Neoadjuvant Therapy
6
2018
477
0.410
Why?
Thoracic Surgical Procedures
4
2026
68
0.410
Why?
Bile Duct Neoplasms
2
2005
106
0.410
Why?
Thiazoles
2
2012
127
0.410
Why?
Salvage Therapy
3
2010
241
0.400
Why?
Folic Acid Antagonists
4
2008
17
0.400
Why?
Maximum Tolerated Dose
14
2021
265
0.400
Why?
Pyrazines
6
2019
98
0.390
Why?
Prospective Studies
22
2024
4837
0.380
Why?
Retrospective Studies
18
2025
11104
0.370
Why?
Radioactive Hazard Release
4
1999
8
0.360
Why?
Epothilones
2
2009
13
0.350
Why?
Pleura
4
2018
30
0.340
Why?
Imidazoles
2
2014
142
0.340
Why?
Venous Thromboembolism
2
2024
178
0.340
Why?
Genetic Testing
4
2026
610
0.340
Why?
User-Computer Interface
6
1999
195
0.340
Why?
B7-H1 Antigen
2
2026
333
0.330
Why?
Neutropenia
9
2019
211
0.320
Why?
Indazoles
1
2011
65
0.320
Why?
Medical Oncology
3
2018
426
0.320
Why?
Polymorphism, Single Nucleotide
6
2024
2577
0.320
Why?
Consensus
4
2025
308
0.310
Why?
Diagnostic Imaging
2
2019
468
0.310
Why?
Platelet-Derived Growth Factor
3
2011
65
0.310
Why?
Proportional Hazards Models
11
2022
925
0.310
Why?
Hyperinsulinism
2
2020
44
0.300
Why?
Indoles
7
2012
340
0.300
Why?
Neuroendocrine Tumors
3
2023
158
0.300
Why?
Child Abuse
1
2010
98
0.300
Why?
Hyperthermia, Induced
2
2024
77
0.290
Why?
Infusions, Intravenous
10
2009
403
0.290
Why?
Preoperative Care
3
2018
420
0.290
Why?
Pleural Effusion, Malignant
1
2009
15
0.290
Why?
Paclitaxel
6
2021
484
0.280
Why?
Polyethylene Glycols
2
2024
383
0.280
Why?
Antineoplastic Agents, Phytogenic
3
2005
272
0.280
Why?
Oxides
1
2008
42
0.280
Why?
Placebos
4
2015
210
0.280
Why?
Purine-Nucleoside Phosphorylase
1
2008
21
0.280
Why?
Carboplatin
6
2021
331
0.280
Why?
Arsenicals
1
2008
49
0.280
Why?
Benzamides
6
2019
260
0.270
Why?
Expert Systems
3
1998
18
0.270
Why?
Mass Screening
2
2011
753
0.270
Why?
Genotype
4
2020
1895
0.270
Why?
Dose-Response Relationship, Drug
14
2019
1949
0.270
Why?
Tomography, Emission-Computed
1
2007
103
0.260
Why?
Life Style
4
2022
193
0.260
Why?
Medical Records Systems, Computerized
2
1999
40
0.260
Why?
Genome-Wide Association Study
5
2024
1863
0.250
Why?
Signal Transduction
5
2016
3642
0.250
Why?
Image Processing, Computer-Assisted
2
2012
1305
0.250
Why?
Cholangiocarcinoma
2
2005
92
0.250
Why?
Hypertension
3
2021
791
0.250
Why?
Databases, Factual
4
2024
1102
0.240
Why?
Dietary Sucrose
2
2018
14
0.240
Why?
Sweetening Agents
2
2018
17
0.240
Why?
Thymidylate Synthase
2
2004
15
0.240
Why?
Internet
2
1999
359
0.240
Why?
TOR Serine-Threonine Kinases
4
2016
224
0.240
Why?
Genetic Privacy
1
2026
17
0.230
Why?
Cancer Survivors
2
2018
110
0.230
Why?
Young Adult
13
2024
7598
0.230
Why?
Vitamin D
3
2018
287
0.220
Why?
Proto-Oncogene Proteins c-met
3
2016
199
0.220
Why?
Precision Medicine
3
2017
512
0.220
Why?
Tumor Microenvironment
3
2025
621
0.220
Why?
Heart Neoplasms
1
2005
52
0.210
Why?
Sulfonamides
5
2019
352
0.210
Why?
Transforming Growth Factor beta2
1
2024
16
0.210
Why?
Genetic Predisposition to Disease
7
2026
2588
0.210
Why?
Oligopeptides
1
2005
205
0.210
Why?
Hydrolases
1
2024
30
0.210
Why?
Aorta, Thoracic
1
2005
154
0.200
Why?
Protein-Tyrosine Kinases
2
2004
305
0.200
Why?
Risk Factors
11
2024
6295
0.200
Why?
Boronic Acids
3
2010
56
0.190
Why?
Models, Theoretical
1
2006
510
0.190
Why?
Benzimidazoles
3
2020
120
0.190
Why?
Drug Resistance, Neoplasm
6
2010
671
0.190
Why?
Gastrointestinal Stromal Tumors
2
2017
23
0.190
Why?
Albumins
2
2020
126
0.190
Why?
Receptor, IGF Type 1
2
2013
45
0.190
Why?
United States
11
2021
8387
0.190
Why?
RNA, Long Noncoding
1
2024
133
0.190
Why?
Mutation
7
2020
4443
0.180
Why?
Magnetic Resonance Angiography
1
2005
284
0.180
Why?
Genomics
3
2023
914
0.180
Why?
Nausea
6
2020
95
0.180
Why?
Exercise
2
2018
384
0.180
Why?
Arthrogryposis
1
2022
8
0.180
Why?
Tumor Burden
4
2024
330
0.180
Why?
Clinical Trials, Phase III as Topic
5
2013
172
0.180
Why?
Red Meat
1
2022
12
0.180
Why?
Pilot Projects
4
2018
978
0.180
Why?
Percutaneous Coronary Intervention
1
2023
81
0.180
Why?
Nucleic Acid Synthesis Inhibitors
1
2021
16
0.180
Why?
Nomograms
1
2022
34
0.170
Why?
Kv1.3 Potassium Channel
1
2021
13
0.170
Why?
Sarcoma
1
2023
222
0.170
Why?
Chicago
2
2020
1520
0.170
Why?
Diagnosis, Computer-Assisted
3
2007
338
0.170
Why?
Enzyme Inhibitors
2
2005
641
0.170
Why?
Proteinuria
1
2021
72
0.170
Why?
Neoplasm Grading
2
2020
425
0.170
Why?
Photography
2
1998
43
0.170
Why?
Neoplasms, Second Primary
1
2023
244
0.170
Why?
Pulmonary Embolism
1
2024
235
0.170
Why?
Carcinoma, Non-Small-Cell Lung
5
2006
1177
0.170
Why?
Beverages
2
2018
17
0.170
Why?
CD40 Antigens
1
2021
43
0.160
Why?
Bridged Bicyclo Compounds, Heterocyclic
3
2016
112
0.160
Why?
Risk Assessment
5
2019
2604
0.160
Why?
Delphi Technique
3
2026
183
0.160
Why?
Patient-Centered Care
1
2023
233
0.160
Why?
Observation
1
2020
38
0.160
Why?
Benzenesulfonates
2
2010
49
0.160
Why?
Disease Management
2
2025
378
0.160
Why?
Uracil
1
2000
58
0.160
Why?
Information Storage and Retrieval
3
2005
129
0.160
Why?
Income
1
2021
103
0.160
Why?
Antibodies, Bispecific
1
2021
51
0.160
Why?
Cell Line, Tumor
10
2018
2913
0.160
Why?
Artificial Intelligence
4
2005
489
0.160
Why?
Fanconi Anemia Complementation Group N Protein
1
2020
18
0.150
Why?
Jews
1
2020
42
0.150
Why?
Oxidoreductases
1
2000
112
0.150
Why?
Aminopterin
1
1999
5
0.150
Why?
Pharmaceutical Preparations
1
2021
109
0.150
Why?
Bone Marrow
2
2007
419
0.150
Why?
Cetuximab
4
2021
119
0.150
Why?
Cytidine Deaminase
1
2019
25
0.150
Why?
Randomized Controlled Trials as Topic
6
2022
995
0.150
Why?
Hematologic Neoplasms
1
2023
384
0.150
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2019
20
0.150
Why?
Cohort Studies
7
2026
3242
0.140
Why?
Universities
2
2010
166
0.140
Why?
Response Evaluation Criteria in Solid Tumors
4
2020
61
0.140
Why?
Leukemia
2
2006
310
0.140
Why?
Listeria monocytogenes
1
2019
98
0.140
Why?
Pancreaticoduodenectomy
1
2019
102
0.140
Why?
Topotecan
1
1998
47
0.140
Why?
Neoplasm Proteins
2
2020
553
0.140
Why?
Multimodal Imaging
1
2019
115
0.140
Why?
Melanoma
2
2022
523
0.140
Why?
Oncogene Proteins, Fusion
1
2019
137
0.140
Why?
Nutrition Policy
1
2018
14
0.140
Why?
Capecitabine
6
2016
103
0.140
Why?
Pancreatectomy
3
2016
222
0.140
Why?
Nuts
1
2018
4
0.140
Why?
Reproducibility of Results
5
2012
2799
0.140
Why?
Seafood
1
2018
11
0.130
Why?
Focal Adhesion Kinase 1
1
2018
30
0.130
Why?
Palliative Care
3
2018
291
0.130
Why?
Sirolimus
3
2023
181
0.130
Why?
Multimedia
1
1998
9
0.130
Why?
Radiodermatitis
1
1998
10
0.130
Why?
Adolescent
5
2024
10168
0.130
Why?
Sarcopenia
1
2018
22
0.130
Why?
Models, Statistical
1
2022
602
0.130
Why?
Erlotinib Hydrochloride
4
2019
88
0.130
Why?
Hospital Information Systems
2
1997
9
0.130
Why?
Receptor Protein-Tyrosine Kinases
2
2011
160
0.130
Why?
Filgrastim
1
2017
56
0.130
Why?
Feasibility Studies
4
2016
818
0.130
Why?
Patient Compliance
2
2018
247
0.130
Why?
Organoids
1
2018
92
0.130
Why?
Receptors, Calcitriol
1
2018
130
0.130
Why?
Vomiting
4
2016
109
0.130
Why?
Fatty Acids, Omega-3
1
2018
57
0.130
Why?
Immunoglobulin G
2
2019
481
0.130
Why?
Radiosurgery
1
2021
352
0.130
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2017
12
0.130
Why?
Time Factors
8
2021
5586
0.130
Why?
Management Information Systems
1
1997
3
0.130
Why?
Computer Communication Networks
1
1997
24
0.120
Why?
Hematopoiesis
2
1995
187
0.120
Why?
Surveys and Questionnaires
6
2018
3058
0.120
Why?
Skin Neoplasms
1
2022
638
0.120
Why?
Sex Factors
2
2019
1144
0.120
Why?
Age Factors
2
2019
1976
0.120
Why?
Skin Diseases
1
1998
178
0.120
Why?
Postoperative Care
1
2017
239
0.120
Why?
Fractals
1
2016
41
0.120
Why?
Decision Support Techniques
1
1998
193
0.120
Why?
Fishes
1
2018
149
0.120
Why?
Academic Medical Centers
1
2019
416
0.120
Why?
Decision Making, Computer-Assisted
2
1995
12
0.120
Why?
Polymorphism, Genetic
1
2019
832
0.120
Why?
Documentation
1
1997
114
0.120
Why?
Karnofsky Performance Status
1
2015
43
0.120
Why?
Radiography, Thoracic
2
2011
331
0.110
Why?
Coffee
1
2015
10
0.110
Why?
Cone-Beam Computed Tomography
1
2016
80
0.110
Why?
Hypoglycemic Agents
1
2019
416
0.110
Why?
Class I Phosphatidylinositol 3-Kinases
1
2016
84
0.110
Why?
Evidence-Based Medicine
1
2018
483
0.110
Why?
Hydroxamic Acids
1
2015
53
0.110
Why?
Mice
9
2018
12762
0.110
Why?
Cosmic Radiation
1
1994
1
0.110
Why?
Solar Activity
1
1994
1
0.110
Why?
Blood Cells
1
1994
32
0.110
Why?
Dasatinib
2
2012
38
0.110
Why?
Gamma Rays
1
1994
72
0.110
Why?
Protein Kinase C
2
2008
267
0.110
Why?
Animals
18
2018
29045
0.100
Why?
Lymphatic Metastasis
3
2015
519
0.100
Why?
Acute Disease
5
1999
864
0.100
Why?
Vascular Endothelial Growth Factor D
1
2013
2
0.100
Why?
Health Status
2
2015
388
0.100
Why?
Odds Ratio
1
2015
728
0.100
Why?
Chemoradiotherapy
1
2016
337
0.100
Why?
Chemokine CXCL12
1
2013
38
0.100
Why?
Niacinamide
2
2010
105
0.100
Why?
Insulin
1
2019
1226
0.100
Why?
Pattern Recognition, Automated
2
2005
218
0.100
Why?
Computer Simulation
1
1998
1152
0.100
Why?
Vesicular Transport Proteins
1
2013
71
0.100
Why?
Neoplasm Invasiveness
3
2017
583
0.100
Why?
Sensitivity and Specificity
4
2012
1946
0.100
Why?
Phosphorylation
5
2018
1148
0.100
Why?
Vitamin D Deficiency
1
2014
118
0.100
Why?
Phenylurea Compounds
2
2010
112
0.100
Why?
World Health Organization
3
1999
125
0.090
Why?
ErbB Receptors
5
2011
517
0.090
Why?
Carcinoma, Hepatocellular
2
2009
455
0.090
Why?
Observer Variation
4
2013
579
0.090
Why?
Cell Movement
5
2018
821
0.090
Why?
Folic Acid
2
2003
68
0.090
Why?
Phosphotransferases (Alcohol Group Acceptor)
1
2012
64
0.090
Why?
Geriatric Assessment
1
2013
193
0.090
Why?
Tomography, Spiral Computed
2
2018
75
0.090
Why?
Thrombospondin 1
1
2011
22
0.090
Why?
Pyrroles
2
2010
166
0.090
Why?
Mitochondria
1
2016
653
0.090
Why?
Symptom Assessment
1
2012
77
0.090
Why?
Carcinoma, Small Cell
2
2006
116
0.090
Why?
Patient Outcome Assessment
1
2012
90
0.090
Why?
Multidetector Computed Tomography
1
2012
58
0.080
Why?
Survivors
1
2013
211
0.080
Why?
Programmed Cell Death 1 Receptor
2
2023
201
0.080
Why?
Radiographic Image Interpretation, Computer-Assisted
2
2024
464
0.080
Why?
Diarrhea
4
2019
180
0.080
Why?
Osteopontin
1
2011
48
0.080
Why?
src-Family Kinases
1
2011
70
0.080
Why?
Drug-Related Side Effects and Adverse Reactions
3
2020
220
0.080
Why?
Pulmonary Atelectasis
1
2010
19
0.080
Why?
Interleukin-17
1
2011
114
0.080
Why?
Genetic Counseling
2
2026
111
0.080
Why?
High-Throughput Nucleotide Sequencing
3
2023
588
0.080
Why?
Administration, Oral
7
2007
677
0.080
Why?
Histones
1
2012
365
0.080
Why?
Reference Standards
1
2010
147
0.080
Why?
Hepatocyte Growth Factor
2
2011
86
0.080
Why?
Proteasome Inhibitors
2
2007
52
0.080
Why?
Probability
3
2024
356
0.080
Why?
Margins of Excision
2
2022
50
0.080
Why?
Biomarkers
2
2014
2026
0.070
Why?
Mice, Nude
3
2016
829
0.070
Why?
Xenograft Model Antitumor Assays
3
2016
559
0.070
Why?
Algorithms
3
2012
2005
0.070
Why?
Protease Inhibitors
2
2010
71
0.070
Why?
Research Design
1
2013
652
0.070
Why?
Pain
1
2011
417
0.070
Why?
Alanine
2
2008
82
0.070
Why?
National Cancer Institute (U.S.)
2
2019
77
0.070
Why?
Confidence Intervals
3
2021
221
0.070
Why?
Proto-Oncogene Proteins p21(ras)
3
2018
186
0.070
Why?
Cancer Vaccines
2
2007
168
0.070
Why?
DNA Repair
2
2021
363
0.070
Why?
Models, Biological
2
1997
1806
0.070
Why?
Quinoxalines
1
2008
51
0.070
Why?
Imatinib Mesylate
2
2007
129
0.070
Why?
Carcinoembryonic Antigen
1
2007
40
0.070
Why?
Immunohistochemistry
4
2023
1818
0.070
Why?
Protein Kinases
1
2009
211
0.070
Why?
Glycolipids
1
2007
27
0.070
Why?
Adenine
1
2008
101
0.070
Why?
Immunotoxins
1
2007
16
0.070
Why?
Morpholines
2
2016
64
0.070
Why?
Imaging, Three-Dimensional
1
2012
634
0.060
Why?
Dermatology
2
1998
48
0.060
Why?
Prevalence
3
2020
1396
0.060
Why?
Anus Neoplasms
1
2007
41
0.060
Why?
Azacitidine
1
2008
152
0.060
Why?
Software
4
2012
698
0.060
Why?
Cell Proliferation
4
2016
1801
0.060
Why?
Aortic Aneurysm
1
2007
72
0.060
Why?
Drug Synergism
3
2016
317
0.060
Why?
Fluorodeoxyglucose F18
1
2007
146
0.060
Why?
Glycoproteins
1
2007
222
0.060
Why?
Neovascularization, Pathologic
2
2018
356
0.060
Why?
Wound Healing
5
2014
385
0.060
Why?
Radiopharmaceuticals
1
2007
214
0.060
Why?
Hepatectomy
2
2007
218
0.060
Why?
Thrombocytopenia
5
2007
194
0.060
Why?
Esophagogastric Junction
2
2010
36
0.060
Why?
Liver Diseases
2
2007
250
0.060
Why?
Paronychia
1
2006
1
0.060
Why?
Heterozygote
2
2018
393
0.060
Why?
Immunity, Cellular
2
2022
187
0.060
Why?
Case-Control Studies
3
2019
2017
0.060
Why?
alpha-Galactosidase
1
2005
5
0.060
Why?
Fabry Disease
1
2005
8
0.060
Why?
Opportunistic Infections
1
2006
57
0.060
Why?
Depsipeptides
1
2005
30
0.060
Why?
Doxycycline
1
2006
41
0.060
Why?
Carotid Artery, Common
1
2005
28
0.060
Why?
Drug Eruptions
1
2005
35
0.060
Why?
Thoracic Surgery
1
2026
71
0.060
Why?
Subclavian Artery
1
2005
43
0.050
Why?
Societies, Medical
2
2026
687
0.050
Why?
Meta-Analysis as Topic
1
2005
87
0.050
Why?
Feeding Behavior
2
2018
354
0.050
Why?
Coronary Circulation
1
2005
97
0.050
Why?
Receptor, trkA
1
2005
16
0.050
Why?
Prodrugs
2
2004
53
0.050
Why?
Carbazoles
1
2005
31
0.050
Why?
Microsatellite Instability
1
2025
69
0.050
Why?
Genetic Therapy
2
2004
374
0.050
Why?
Kidney Diseases
1
2007
313
0.050
Why?
Proto-Oncogene Proteins c-raf
1
2004
51
0.050
Why?
RNA, Messenger
3
2018
2076
0.050
Why?
Comorbidity
1
2008
1037
0.050
Why?
Oligonucleotides, Antisense
1
2004
70
0.050
Why?
Incidental Findings
1
2005
100
0.050
Why?
Liposomes
1
2004
105
0.050
Why?
Cyclosporine
1
2005
241
0.050
Why?
Carcinoid Tumor
1
2004
45
0.050
Why?
Vaccination
2
2022
328
0.050
Why?
Coronary Disease
1
2005
227
0.050
Why?
Proto-Oncogene Proteins
3
2013
687
0.050
Why?
Pyrrolidines
1
2004
61
0.050
Why?
Myocardial Infarction
1
2007
397
0.050
Why?
Peritoneum
1
2023
52
0.050
Why?
Remission Induction
1
2005
764
0.050
Why?
Arginine
1
2024
144
0.050
Why?
Hematinics
1
2003
12
0.050
Why?
Bortezomib
3
2010
83
0.050
Why?
Treatment Failure
2
2004
300
0.050
Why?
Radiotherapy
2
2006
325
0.050
Why?
DNA Methylation
1
2008
735
0.050
Why?
Flavonoids
1
2003
86
0.050
Why?
PTEN Phosphohydrolase
2
2014
154
0.050
Why?
Drug Therapy, Combination
3
2018
766
0.050
Why?
DNA Helicases
1
2023
94
0.050
Why?
Vitamin B 12
1
2002
25
0.050
Why?
Apoptosis
3
2016
1754
0.050
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2019
114
0.050
Why?
Antibody Formation
2
2022
173
0.050
Why?
Granulation Tissue
3
1969
15
0.050
Why?
Image Enhancement
1
2005
503
0.050
Why?
Adrenal Insufficiency
1
2022
23
0.050
Why?
DNA, Antisense
1
2002
15
0.050
Why?
Positron-Emission Tomography
2
2020
354
0.050
Why?
Marital Status
1
2022
44
0.050
Why?
Vaccines, Synthetic
1
2022
61
0.040
Why?
Piperidines
1
2003
177
0.040
Why?
Anti-Bacterial Agents
2
2006
885
0.040
Why?
Fatigue
2
2019
187
0.040
Why?
Epidemiologic Methods
1
2001
60
0.040
Why?
Ascites
1
2022
55
0.040
Why?
Infusions, Intra-Arterial
1
2001
42
0.040
Why?
Point-of-Care Systems
1
2023
155
0.040
Why?
Multicenter Studies as Topic
1
2022
195
0.040
Why?
ras Proteins
2
2013
137
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
2021
58
0.040
Why?
Angiopoietin-2
1
2021
23
0.040
Why?
Isoenzymes
1
2002
272
0.040
Why?
Hepatic Artery
1
2001
85
0.040
Why?
Image Interpretation, Computer-Assisted
1
2005
645
0.040
Why?
Positron Emission Tomography Computed Tomography
1
2022
108
0.040
Why?
Microtubules
2
2016
142
0.040
Why?
France
1
2021
53
0.040
Why?
Radiotherapy, Intensity-Modulated
2
2016
200
0.040
Why?
Mitotic Index
1
2020
22
0.040
Why?
Platinum Compounds
1
2020
29
0.040
Why?
Dihydrouracil Dehydrogenase (NADP)
1
2000
28
0.040
Why?
Anticoagulants
1
2024
486
0.040
Why?
Israel
1
2020
69
0.040
Why?
Antibodies, Viral
1
2022
342
0.040
Why?
Immunosuppressive Agents
1
2005
1021
0.040
Why?
T-Lymphocytes
2
2022
1335
0.040
Why?
Severity of Illness Index
1
2006
2025
0.040
Why?
Quantitative Trait Loci
1
2024
665
0.040
Why?
Australia
1
2020
126
0.040
Why?
Canada
1
2020
210
0.040
Why?
Cell Cycle
2
2014
519
0.040
Why?
Administration, Intravenous
1
2019
64
0.040
Why?
Contrast Media
1
2004
1014
0.040
Why?
Heart Diseases
1
2001
269
0.040
Why?
Fibroblast Growth Factor 2
1
2019
57
0.040
Why?
Acetals
1
1999
2
0.040
Why?
Neurokinin-1 Receptor Antagonists
1
1999
12
0.040
Why?
Constipation
1
2020
69
0.040
Why?
Thoracic Neoplasms
1
2019
63
0.040
Why?
International Cooperation
1
1999
133
0.040
Why?
Down-Regulation
1
2020
529
0.040
Why?
Antiemetics
1
1999
28
0.040
Why?
Platinum
1
2019
68
0.040
Why?
Protein Methyltransferases
1
2018
15
0.040
Why?
Infusion Pumps
1
1998
26
0.040
Why?
Area Under Curve
3
2004
341
0.040
Why?
Topoisomerase I Inhibitors
1
1998
35
0.040
Why?
Child
1
2010
7771
0.040
Why?
NFATC Transcription Factors
1
2018
52
0.030
Why?
Multivariate Analysis
1
2021
1007
0.030
Why?
Cyclophosphamide
1
2019
285
0.030
Why?
Focal Adhesion Kinase 2
1
2018
12
0.030
Why?
Diet Records
1
2018
20
0.030
Why?
Nutritive Value
1
2018
7
0.030
Why?
Protective Factors
1
2018
30
0.030
Why?
Cell Nucleus
1
2020
616
0.030
Why?
Power Plants
1
1998
5
0.030
Why?
Energy Intake
1
2018
100
0.030
Why?
Up-Regulation
1
2020
742
0.030
Why?
Sulfones
1
2018
48
0.030
Why?
Ukraine
1
1998
27
0.030
Why?
Ligands
1
2019
492
0.030
Why?
Cyclooxygenase 2
1
2018
101
0.030
Why?
Quinolones
1
2018
59
0.030
Why?
Histone-Lysine N-Methyltransferase
1
2018
171
0.030
Why?
Patient Care Planning
1
1998
92
0.030
Why?
Recombinant Fusion Proteins
1
2019
557
0.030
Why?
Illinois
1
2019
531
0.030
Why?
Cell Culture Techniques
1
2018
198
0.030
Why?
Cost Control
1
1997
44
0.030
Why?
RNA, Small Interfering
2
2011
573
0.030
Why?
Patient Safety
1
2019
237
0.030
Why?
Epithelioid Cells
1
2016
13
0.030
Why?
Risk
1
2018
662
0.030
Why?
Cell Adhesion
1
2018
421
0.030
Why?
Efficiency, Organizational
1
1997
55
0.030
Why?
Global Health
1
1998
216
0.030
Why?
Drug Evaluation, Preclinical
2
2007
111
0.030
Why?
Neoplasms, Experimental
1
2018
263
0.030
Why?
Cell Cycle Checkpoints
1
2016
68
0.030
Why?
Veratrum Alkaloids
1
2016
9
0.030
Why?
CA-19-9 Antigen
1
2016
14
0.030
Why?
Aminopyridines
1
2016
54
0.030
Why?
Anemia
3
2007
135
0.030
Why?
Radiography
2
2010
763
0.030
Why?
Health Services Accessibility
1
2021
548
0.030
Why?
Lymphokines
2
2002
74
0.030
Why?
Tea
1
2015
19
0.030
Why?
Leukopenia
2
2007
66
0.030
Why?
Pyrazoles
1
2016
162
0.030
Why?
Autoradiography
3
1967
52
0.030
Why?
Total Lung Capacity
1
2015
11
0.030
Why?
Magnetic Resonance Imaging
2
2004
3622
0.030
Why?
Mitochondrial Proteins
1
2016
131
0.030
Why?
Neoplasm, Residual
1
2016
205
0.030
Why?
Organ Size
1
2016
370
0.030
Why?
Glycolysis
1
2016
198
0.030
Why?
Alcohol Drinking
1
2018
302
0.030
Why?
Bone Marrow Diseases
1
1995
38
0.030
Why?
Systems Integration
1
1995
36
0.030
Why?
Space Flight
1
1994
8
0.030
Why?
Decision Trees
1
1995
63
0.030
Why?
Pyrrolidinones
1
2014
15
0.030
Why?
Hemodynamics
2
2018
749
0.030
Why?
Recurrence
1
2018
1274
0.030
Why?
Anthropometry
1
1995
77
0.030
Why?
Aerospace Medicine
1
1994
17
0.030
Why?
Metformin
1
2016
134
0.030
Why?
Leukocyte Count
1
1995
215
0.030
Why?
Mathematics
1
1994
176
0.030
Why?
Caffeine
1
2015
86
0.030
Why?
cdc25 Phosphatases
1
2014
19
0.030
Why?
Dose-Response Relationship, Radiation
1
1994
193
0.030
Why?
Nervous System Diseases
1
2016
169
0.030
Why?
Body Mass Index
1
2018
869
0.030
Why?
Mice, Transgenic
1
2018
1608
0.030
Why?
Colon
1
2018
566
0.030
Why?
Quinolines
1
2014
97
0.030
Why?
Educational Status
1
2014
206
0.030
Why?
Education, Medical
1
1997
233
0.030
Why?
Radiation Tolerance
1
1994
179
0.020
Why?
Diagnostic Errors
1
1995
161
0.020
Why?
SEER Program
1
2014
252
0.020
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2013
5
0.020
Why?
Carcinoma, Squamous Cell
1
2000
1107
0.020
Why?
Dogs
1
1994
642
0.020
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2013
21
0.020
Why?
Stomatitis
2
2004
30
0.020
Why?
Phosphatidylinositol 3-Kinases
1
2014
286
0.020
Why?
Rats
4
1994
4079
0.020
Why?
Radiation Dosage
1
1994
233
0.020
Why?
Lung Volume Measurements
1
2013
24
0.020
Why?
Incidence
1
2018
1798
0.020
Why?
Patient Selection
2
2013
725
0.020
Why?
Chromosome Aberrations
1
2014
353
0.020
Why?
Recovery of Function
1
2015
373
0.020
Why?
Insulin-Like Growth Factor I
1
2013
118
0.020
Why?
Breast
1
1995
317
0.020
Why?
Family
1
2014
330
0.020
Why?
Macrophage Colony-Stimulating Factor
1
2012
18
0.020
Why?
Acetylation
1
2012
151
0.020
Why?
Chromatin Immunoprecipitation
1
2012
139
0.020
Why?
Bone Neoplasms
2
2010
316
0.020
Why?
Postoperative Complications
1
2024
2719
0.020
Why?
Peptide Fragments
1
2014
480
0.020
Why?
Social Behavior
1
2015
318
0.020
Why?
Immunoblotting
1
2012
273
0.020
Why?
Registries
1
2018
1133
0.020
Why?
Tandem Mass Spectrometry
1
2012
108
0.020
Why?
Proteins
3
1963
804
0.020
Why?
Liver
3
2004
1231
0.020
Why?
alpha 1-Antichymotrypsin
1
2011
4
0.020
Why?
Receptors, Growth Factor
1
2011
52
0.020
Why?
Chromosomal Instability
1
2011
22
0.020
Why?
Ploidies
1
2011
39
0.020
Why?
Loss of Heterozygosity
1
2011
85
0.020
Why?
STAT3 Transcription Factor
1
2011
91
0.020
Why?
Amino Acid Substitution
1
2011
336
0.020
Why?
Medicare
1
2014
528
0.020
Why?
Gene Dosage
1
2011
216
0.020
Why?
Neoplastic Cells, Circulating
1
2011
78
0.020
Why?
Psychometrics
1
2012
359
0.020
Why?
In Situ Hybridization, Fluorescence
1
2011
369
0.020
Why?
Linkage Disequilibrium
1
2011
484
0.020
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
125
0.020
Why?
Hematopoietic Stem Cell Transplantation
1
1997
979
0.020
Why?
Taxoids
1
2009
127
0.020
Why?
Mucositis
1
2009
18
0.020
Why?
Haptens
2
1988
9
0.020
Why?
Early Detection of Cancer
1
2014
563
0.020
Why?
Muscle, Skeletal
3
2004
523
0.020
Why?
Phorbol Esters
1
2008
19
0.020
Why?
Protein Kinase C beta
1
2008
13
0.020
Why?
Inhibitory Concentration 50
1
2008
61
0.020
Why?
Biopsy
1
2012
1226
0.020
Why?
Cell Line
1
2012
2484
0.020
Why?
Fibronectins
1
1988
104
0.020
Why?
Mitomycin
1
2007
30
0.020
Why?
Antibodies, Anti-Idiotypic
1
2007
45
0.020
Why?
Tritium
2
1967
114
0.020
Why?
Lipid Droplets
1
2007
21
0.020
Why?
Leucine
2
1967
57
0.020
Why?
Phosphoproteins
1
2009
264
0.020
Why?
Genes, Intracisternal A-Particle
1
2007
3
0.020
Why?
Obesity
1
1995
1079
0.020
Why?
NF-kappa B
1
2010
424
0.020
Why?
Drug Resistance, Multiple
1
2007
20
0.020
Why?
Liver Function Tests
1
2007
95
0.020
Why?
Injections, Intravenous
1
2007
215
0.020
Why?
Pelvis
1
2007
106
0.020
Why?
Cortisone
1
1967
9
0.020
Why?
Kidney Function Tests
1
2007
124
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2007
80
0.020
Why?
Hydrocortisone
1
1969
305
0.020
Why?
Clinical Trials, Phase I as Topic
2
1998
154
0.020
Why?
Gastrectomy
1
2007
75
0.020
Why?
Radiotherapy Dosage
1
2007
478
0.020
Why?
Regression Analysis
1
2007
578
0.010
Why?
Glucocorticoids
1
1969
371
0.010
Why?
Cell Cycle Proteins
1
2009
420
0.010
Why?
Polymerase Chain Reaction
1
2008
895
0.010
Why?
Mitogen-Activated Protein Kinase 3
1
2006
68
0.010
Why?
Cell Growth Processes
1
2006
83
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2006
77
0.010
Why?
Hyperemia
1
2005
17
0.010
Why?
Epidermal Growth Factor
1
2006
116
0.010
Why?
Flow Cytometry
1
2007
722
0.010
Why?
Microcirculation
1
2005
101
0.010
Why?
National Institutes of Health (U.S.)
1
2006
140
0.010
Why?
Furans
1
2005
19
0.010
Why?
Avidin
1
1984
5
0.010
Why?
Phenylenediamines
1
2004
6
0.010
Why?
Mice, Inbred C57BL
1
2012
3628
0.010
Why?
Cell Survival
1
2007
1018
0.010
Why?
Drug Interactions
1
2005
240
0.010
Why?
Metabolic Clearance Rate
1
2004
118
0.010
Why?
Biotin
1
1984
45
0.010
Why?
Electrocardiography
1
2007
528
0.010
Why?
Receptors, Endothelin
1
2004
12
0.010
Why?
Enzyme Activation
1
2006
679
0.010
Why?
Ovalbumin
1
1984
106
0.010
Why?
Transaminases
1
2004
32
0.010
Why?
Numerical Analysis, Computer-Assisted
1
2004
34
0.010
Why?
Myocardial Ischemia
1
2005
143
0.010
Why?
Proto-Oncogene Proteins c-akt
1
2006
369
0.010
Why?
Gene Transfer Techniques
1
2004
155
0.010
Why?
Connective Tissue Cells
1
1963
1
0.010
Why?
Neoplasm Transplantation
1
2004
400
0.010
Why?
Connective Tissue
1
1963
20
0.010
Why?
Histone Deacetylase Inhibitors
1
2004
109
0.010
Why?
Leukocytes, Mononuclear
1
2004
213
0.010
Why?
Gadolinium DTPA
1
2004
239
0.010
Why?
Skin Transplantation
1
1964
194
0.010
Why?
Diagnosis, Differential
1
2007
1571
0.010
Why?
Signal Processing, Computer-Assisted
1
2004
197
0.010
Why?
Cluster Analysis
1
2004
401
0.010
Why?
Quality Assurance, Health Care
1
2004
229
0.010
Why?
Gene Expression Regulation, Neoplastic
1
2008
1400
0.010
Why?
Base Sequence
1
2006
2224
0.010
Why?
Research
1
1963
258
0.010
Why?
Protein Kinase C-alpha
1
2002
29
0.010
Why?
Vascular Endothelial Growth Factors
1
2002
54
0.010
Why?
Thionucleotides
1
2002
54
0.010
Why?
Endothelial Growth Factors
1
2002
55
0.010
Why?
Razoxane
1
2001
3
0.010
Why?
Radiographic Image Enhancement
1
2004
449
0.010
Why?
Oxonic Acid
1
2001
8
0.010
Why?
Tegafur
1
2001
17
0.010
Why?
Molecular Sequence Data
1
2006
2897
0.010
Why?
Oligonucleotides
1
2002
93
0.010
Why?
Interferons
1
2002
114
0.010
Why?
Drug Combinations
1
2001
202
0.010
Why?
Carcinoma
1
2004
442
0.010
Why?
Adjuvants, Immunologic
1
2002
177
0.010
Why?
Doxorubicin
1
2001
285
0.010
Why?
Muscles
2
1952
179
0.010
Why?
Antigen Presentation
1
2002
234
0.010
Why?
Immunologic Factors
1
2002
180
0.010
Why?
Fibroblasts
1
1963
767
0.010
Why?
Phenotype
1
2007
2673
0.010
Why?
Electrophoresis, Paper
1
1959
2
0.010
Why?
Knee
1
1959
23
0.010
Why?
Antigens, Neoplasm
1
2002
366
0.010
Why?
Hypoxia
1
2004
685
0.010
Why?
Blood Proteins
1
1959
147
0.010
Why?
Granisetron
1
1999
1
0.010
Why?
Serotonin Antagonists
1
1999
24
0.010
Why?
Appendicitis
1
1959
72
0.010
Why?
Perfusion
3
1969
272
0.010
Why?
Knee Joint
1
1959
181
0.010
Why?
Antibiotics, Antitubercular
1
1958
5
0.010
Why?
Cost-Benefit Analysis
1
2001
521
0.010
Why?
Osteomyelitis
1
1958
58
0.010
Why?
Cytokines
1
2002
890
0.010
Why?
Triazines
1
1997
55
0.010
Why?
Dermatologic Agents
1
1958
81
0.010
Why?
Dexamethasone
1
1999
318
0.010
Why?
Growth Substances
1
1997
79
0.010
Why?
Databases as Topic
1
1997
96
0.010
Why?
Clinical Trials, Phase II as Topic
1
1997
168
0.010
Why?
Radiometry
1
1997
64
0.010
Why?
Empyema
1
1956
9
0.010
Why?
Empyema, Pleural
1
1956
11
0.010
Why?
Pheochromocytoma
1
1956
54
0.010
Why?
Syndrome
1
1997
444
0.010
Why?
Giant Cell Tumors
1
1955
4
0.010
Why?
Bone Cysts
1
1955
7
0.010
Why?
Patient Satisfaction
1
1999
519
0.010
Why?
Cysts
1
1955
100
0.010
Why?
Switzerland
1
1973
19
0.010
Why?
Education, Nursing, Continuing
1
1973
13
0.010
Why?
Prostatic Neoplasms
1
2004
1846
0.010
Why?
Liver Circulation
2
1969
28
0.010
Why?
Teaching
1
1973
145
0.010
Why?
Foot Deformities
1
1952
9
0.010
Why?
Flatfoot
1
1952
14
0.010
Why?
Hepatic Encephalopathy
2
1969
35
0.010
Why?
Foot
1
1952
64
0.010
Why?
Leg
1
1952
145
0.010
Why?
Knee Dislocation
1
1951
6
0.010
Why?
Patellar Dislocation
1
1951
15
0.010
Why?
Relaxation
1
1950
2
0.000
Why?
Knee Injuries
1
1951
57
0.000
Why?
Learning
1
1973
313
0.000
Why?
Depression, Chemical
1
1969
25
0.000
Why?
Assisted Circulation
1
1969
16
0.000
Why?
Cell-Free System
1
1988
45
0.000
Why?
Cell Fractionation
1
1988
64
0.000
Why?
Gelatin
1
1988
27
0.000
Why?
Clone Cells
1
1988
223
0.000
Why?
Heparin
1
1988
182
0.000
Why?
Aminocaproates
1
1984
4
0.000
Why?
Dinitrobenzenes
1
1984
5
0.000
Why?
Binding, Competitive
1
1984
136
0.000
Why?
Macromolecular Substances
1
1984
162
0.000
Why?
Mice, Inbred Strains
1
1984
281
0.000
Why?
Enzyme-Linked Immunosorbent Assay
1
1984
374
0.000
Why?
Lysine
1
1984
170
0.000
Why?
Cells, Cultured
1
1988
2859
0.000
Why?
Swine
3
1969
593
0.000
Why?
Peptides
1
1984
671
0.000
Why?
Bile
2
1969
60
0.000
Why?
Sulfobromophthalein
1
1969
1
0.000
Why?
Exchange Transfusion, Whole Blood
1
1969
15
0.000
Why?
Methods
1
1969
134
0.000
Why?
Hematocrit
1
1969
68
0.000
Why?
Electrolytes
1
1969
52
0.000
Why?
Bicarbonates
1
1969
59
0.000
Why?
Extracorporeal Circulation
1
1969
37
0.000
Why?
Alanine Transaminase
1
1969
74
0.000
Why?
L-Lactate Dehydrogenase
1
1969
71
0.000
Why?
Aspartate Aminotransferases
1
1969
74
0.000
Why?
Alkaline Phosphatase
1
1969
129
0.000
Why?
Bilirubin
1
1969
135
0.000
Why?
Hemoglobins
1
1969
197
0.000
Why?
Hydrogen-Ion Concentration
1
1969
489
0.000
Why?
Oxygen
1
1969
777
0.000
Why?
Kindler's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (792)
Explore
_
Co-Authors (85)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_